ArticleThe Journal of veterinary medical science2026
Efficacy of dual therapy with rivaroxaban and clopidogrel in canine aortic thrombosis resistant to clopidogrel monotherapy: two case reports.
Article in The Journal of veterinary medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aortic thrombotic disease occurs in both dogs and cats. In dogs, it typically presents as aortic thrombosis (ATh), whereas in cats, it most commonly manifests as aortic thromboembolism (ATE). Canine ATh is rare, with no standardized treatment. Rivaroxaban, a direct factor Xa inhibitor, is increasingly used in veterinary medicine. Recently, the efficacy of dual antithrombotic therapy with clopidogrel and rivaroxaban in feline ATE has been suggested. Here, we report two canine ATh cases. Clopidogrel monotherapy was insufficient, but adding rivaroxaban improved gait, relieved pain, and reduced thrombus size on ultrasonography. This combination therapy may be effective for canine ATh, as has been suggested for feline ATE. Further case studies are needed to evaluate the efficacy of rivaroxaban for canine ATh.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.